Ren C - Search Results

1

Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.

Ren C, Kumar S, Chanda D, Kallman L, Chen J, Mountz JD, Ponnazhagan S. Ren C, et al. Gene Ther. 2008 Nov;15(21):1446-53. doi: 10.1038/gt.2008.101. Epub 2008 Jul 3. Gene Ther. 2008. PMID: 18596829 Free PMC article.

2

Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.

Aldrich WA, Ren C, White AF, Zhou SZ, Kumar S, Jenkins CB, Shaw DR, Strong TV, Triozzi PL, Ponnazhagan S. Aldrich WA, et al. Among authors: ren c. Gene Ther. 2006 Jan;13(1):29-39. doi: 10.1038/sj.gt.3302601. Gene Ther. 2006. PMID: 16136165

3

Intraperitoneal gene therapy by rAAV provides long-term survival against epithelial ovarian cancer independently of survivin pathway.

Isayeva T, Ren C, Ponnazhagan S. Isayeva T, et al. Among authors: ren c. Gene Ther. 2007 Jan;14(2):138-46. doi: 10.1038/sj.gt.3302853. Epub 2006 Aug 31. Gene Ther. 2007. PMID: 16943851

4

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.

Fujita T, Timme TL, Tabata K, Naruishi K, Kusaka N, Watanabe M, Abdelfattah E, Zhu JX, Ren C, Ren C, Yang G, Goltsov A, Wang H, Vlachaki MT, Teh BS, Butler EB, Thompson TC. Fujita T, et al. Among authors: ren c. Gene Ther. 2007 Feb;14(3):227-36. doi: 10.1038/sj.gt.3302788. Epub 2006 Oct 5. Gene Ther. 2007. PMID: 17024109

5

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.

Miles BJ, Shalev M, Aguilar-Cordova E, Timme TL, Lee HM, Yang G, Adler HL, Kernen K, Pramudji CK, Satoh T, Gdor Y, Ren C, Ayala G, Wheeler TM, Butler EB, Kadmon D, Thompson TC. Miles BJ, et al. Among authors: ren c. Hum Gene Ther. 2001 Nov 1;12(16):1955-67. doi: 10.1089/104303401753204535. Hum Gene Ther. 2001. PMID: 11686937 Clinical Trial.

6

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression.

Shaker MR, Yang G, Timme TL, Park SH, Kadmon D, Ren C, Ji X, Lee HM, Sehgal I, Anzano M, Sporn MB, Thompson TC. Shaker MR, et al. Among authors: ren c. Clin Exp Metastasis. 2000;18(5):429-38. doi: 10.1023/a:1010905309570. Clin Exp Metastasis. 2000. PMID: 11467776

7

In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.

Pramudji C, Shimura S, Ebara S, Yang G, Wang J, Ren C, Yuan Y, Tahir SA, Timme TL, Thompson TC. Pramudji C, et al. Among authors: ren c. Clin Cancer Res. 2001 Dec;7(12):4272-9. Clin Cancer Res. 2001. PMID: 11751529

8

Metastasis-related genes in prostate cancer.

Bangma CH, Nasu Y, Ren C, Thompson TC. Bangma CH, et al. Among authors: ren c. Semin Oncol. 1999 Aug;26(4):422-7. Semin Oncol. 1999. PMID: 10482184 Review.

9

Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.

Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme TL, Ren C, Wang J, Tahir SA, Thompson TC. Li L, et al. Among authors: ren c. Cancer Res. 2001 Jun 1;61(11):4386-92. Cancer Res. 2001. PMID: 11389065

10

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G. Thompson TC, et al. Among authors: ren c. Oncogene. 1995 Mar 2;10(5):869-79. Oncogene. 1995. PMID: 7534899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,436 results

Search Page

Filters